Aigen Investment Management, LP Edwards Lifesciences Corp Transaction History

Aigen Investment Management, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$72.54 - $95.56 $328,751 - $433,077	4,532 New	4,532 $433,000
Q4 2022 Feb 10, 2023	BUY	$68.3 - $87.44 $6.75 Million - $8.64 Million	98,859 New	98,859 $7.38 Million
Q1 2022 May 05, 2022	SELL	$101.96 - $128.34 $1.02 Million - $1.29 Million	-10,042 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$106.37 - $130.68 $1.07 Million - $1.31 Million	10,042 New	10,042 $1.27 Million
Q2 2021 Aug 10, 2021	SELL	$83.84 - $104.76 $252,358 - $315,327	-3,010 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$78.68 - $90.67 $236,826 - $272,916	3,010 New	3,010 $252,000
Q4 2020 Feb 12, 2021	SELL	$71.69 - $91.23 $245,179 - $312,006	-3,420 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$67.19 - $87.44 $1.06 Million - $1.38 Million	-15,838 Reduced 82.24%	3,420 $273,000
Q2 2020 Aug 10, 2020	BUY	$57.54 - $76.95 $428,040 - $572,431	7,439 Added 62.94%	19,258 $1.33 Million
Q1 2020 May 08, 2020	BUY	$52.41 - $81.0 $606,960 - $938,061	11,581 Added 4865.97%	11,819 $2.23 Million
Q4 2019 Feb 04, 2020	BUY	$71.7 - $82.09 $17,064 - $19,537	238 New	238 $56,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.